4//SEC Filing
Marks Gilbert Lynn 4
Accession 0000950170-24-139797
CIK 0001880438other
Filed
Dec 22, 7:00 PM ET
Accepted
Dec 23, 6:38 PM ET
Size
4.6 KB
Accession
0000950170-24-139797
Insider Transaction Report
Form 4
Marks Gilbert Lynn
Director
Transactions
- Award
Common Stock
2024-12-19+8,972→ 31,802 total
Footnotes (1)
- [F1]Represents shares issued in lieu of cash compensation under the issuer's non-employee director compensation policy. All shares vest immediately.
Documents
Issuer
AN2 Therapeutics, Inc.
CIK 0001880438
Entity typeother
Related Parties
1- filerCIK 0001916940
Filing Metadata
- Form type
- 4
- Filed
- Dec 22, 7:00 PM ET
- Accepted
- Dec 23, 6:38 PM ET
- Size
- 4.6 KB